Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2003
02/06/2003WO2002079490A3 Bio-barcodes based on oligonucleotide-modified particles
02/06/2003WO2002077160A3 Methods of making and uses of compositions that modulate intronic region-encoded protein function
02/06/2003WO2002075287A3 Method for detecting biochemical reactions and a measurement carrier for carrying out the method
02/06/2003WO2002063005A3 Lipid-associated molecules
02/06/2003WO2002061126A3 The preparation of polynucleotide arrays
02/06/2003WO2002061110A3 Nucleic acid derivatives
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002059613A3 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
02/06/2003WO2002052037A3 Method for screening and/or identifying factors that bind to nucleic acids
02/06/2003WO2002045323A3 Data relationship model
02/06/2003WO2002042735A9 Human kcr1 regulation of herg potassium channel block
02/06/2003WO2002042497A3 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids
02/06/2003WO2002042485A3 Methods and computer software products for selecting nucleic acid probes
02/06/2003WO2002032926A3 Haplotypes of the ccbp2 gene
02/06/2003WO2002032291A3 Imaging of enzymatic activity
02/06/2003WO2002022651A3 Haplotypes of the ccr8 gene
02/06/2003WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
02/06/2003WO2002020836A3 Method of sequencing dna
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002018414A3 Haplotypes of the bf gene
02/06/2003WO2002016633A3 Methods for identifying inhibitors of ubiquitin-mediated proteolysis of ikb
02/06/2003WO2002010373A3 Apparatus and method for specific release of captured extension products
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2002006833A9 Improved non-luminescent substrate
02/06/2003WO2002004668A3 Improved capture and detection of target nucleic acid in dipstick assays
02/06/2003WO2002004596A9 Diagnosing and treating cancer cells using mutant viruses
02/06/2003WO2002002763A3 Recombinant staphylococcus aureus peptide deformylase
02/06/2003WO2002000919A3 Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring
02/06/2003WO2002000100A9 Method for separation, identification and evaluation of microbes and cells
02/06/2003WO2001094617A3 Protein fragment complementation assay based on beta-lactamase
02/06/2003WO2001088199A3 Identification and modulationof of a t helper-1 and t helper-2 cells
02/06/2003WO2001084157A3 Compositions for detection of multiple analytes
02/06/2003WO2001081614A3 Cell proliferation assay
02/06/2003WO2001079855A3 Method for quantification of akt protein expression
02/06/2003WO2001079548A3 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
02/06/2003WO2001075179A3 Preprocalcitonin as tumor rejection antigen precursor and uses thereof
02/06/2003WO2001075171B1 Methods, compositions and kits for the detection and monitoring of breast cancer
02/06/2003WO2001073123A3 Nanoparticles having oligonucleotides attached thereto and uses therefor
02/06/2003WO2001071034A9 Methods and apparatus for parallel magnetic biological analysis and manipulation
02/06/2003WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/06/2003WO2001029251A8 Improved mutation analysis of the nf1 gene
02/06/2003US20030028927 Detecting genome vvariation in plants; obtain plant, extract nucleotide sequences, incubate with probe, monitor pattern, compare to control, detect adjsustment in hybridization pattern
02/06/2003US20030028926 Recovering human nucleotide sequences from plant genome; obtain human clone from library, incubate with plant cells, transform, recover trangenic plants, propagate, detect snd recover library sequences in offspring genome
02/06/2003US20030028922 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
02/06/2003US20030028916 Determining the genetic similarities between plant species; obtain plants, extract nucleotide sequences, generate nucleotide sequence fingerprint, compare to control, detect genomic similarities
02/06/2003US20030028908 Apparatus for microinjection of sample into amphibian oocytes
02/06/2003US20030028011 Screening effectiveness of viricides; obtain virally infected cells, expose to viricide, monitor viral gene expression, reduced viral expression indicates viricides
02/06/2003US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders
02/06/2003US20030028006 Cytokine receptor common gamma chain like
02/06/2003US20030027999 143 human secreted proteins
02/06/2003US20030027989 Nucleotide seq uences coding polypeptide for use in the diagnosis and treatment of cancer
02/06/2003US20030027985 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders
02/06/2003US20030027981 Urokinase-type plasminogen activator receptor
02/06/2003US20030027867 Use of R-NSAID compounds for anti-HIV treatment
02/06/2003US20030027781 Contacting mixture of nucleic acid sequences with blood brain barrier or CSF-blood barrier tissue; partitioning increased affinity nucleic acids from candidate mixture; amplifying increased to yield a mixture of nucleic acids
02/06/2003US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed
02/06/2003US20030027775 Used for detecting the presence or absence of any specific target nucleic acid sequence contained in a sample
02/06/2003US20030027774 For diagnosis and therapy of tuberculosis
02/06/2003US20030027764 Novel therapeutic and prophylactic agents and methods of using same
02/06/2003US20030027759 Method of using PON-1 to decrease atheroma formation
02/06/2003US20030027754 As pharmaceuticals, diagnostics, biosensors and bioreactors
02/06/2003US20030027749 For use in therapy, and diagnostic assays
02/06/2003US20030027746 Useful in the development of human therapeutics and diagnostic formulations
02/06/2003US20030027743 Tripeptidylpeptidase inhibitors
02/06/2003US20030027352 Multiple-site reaction apparatus and method
02/06/2003US20030027320 Promoters for regulated gene expression
02/06/2003US20030027319 Artificial antibody polypeptides
02/06/2003US20030027317 Enzymatic polypeptide for use as tool in the treatment of viral diseases
02/06/2003US20030027313 Cloned genes encoding reverse transcriptase lacking RNase H activity
02/06/2003US20030027303 Nucleotide sequences coding enzyme inhibitors for use in biological pest control
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027281 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027268 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
02/06/2003US20030027256 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
02/06/2003US20030027254 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease
02/06/2003US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer
02/06/2003US20030027251 Assays for inhibitors of FtsH
02/06/2003US20030027250 Methods and compositions for use in spliceosome mediated RNA trans-splicing
02/06/2003US20030027248 Human cDNAs and proteins and uses thereof
02/06/2003US20030027246 Prostate protein for use in the diagnosis and treatment of cancer
02/06/2003US20030027243 Screening or testing fungicide; obtain fungal protein sample, incubate with test modulator, monitor interaction between fungicide and protein, adjustment in protein activity indicate fungicide
02/06/2003US20030027242 Methods, compositions and kits for biological indicator of sterilization
02/06/2003US20030027241 For detection of bacteria based on recognition and infection of one or more selected strains of bacteria with bacteriophage genetically modified to cause production of an inducer molecule in the bacterium following phage infection
02/06/2003US20030027239 Creatinine biosensor
02/06/2003US20030027238 Optical molecular sensors for cytochrome P450 activity
02/06/2003US20030027236 Detection of enzymatic activity in sample; obtain sample containing enzyme, incubate with substrate and reaction mixture, monitor phosphorylation and dephosphorylation, compare to control, quantify enzyme activity
02/06/2003US20030027231 Generation of biosensor; obtain sample microorganism, incubate with stain, perform spectrum analysis, classify microorganism and biosensor
02/06/2003US20030027230 Detection of antiproliferative agents for treatment of ovarian cancer; obtain cells, incubate with modulator, monitor cells for reduction in cancer activity, reduction in cancer activity indicates antiproliferative agents
02/06/2003US20030027224 Monitoring immunosuppressive activity of compound; obtain sample containing calmodulin dependent kinase, incubate with substrate, expose to modulator, monitor phosphorylation, reduction in phosphorylation indicates suppressive activity
02/06/2003US20030027221 High-throughput screening assays by encapsulation
02/06/2003US20030027220 Chemical modification
02/06/2003US20030027208 Detection of agonist ligands of progesterone receptors; obtain sample contain progesterone receptor, incubate with agonist, monitor receptor binding activity
02/06/2003US20030027206 Automated method for determining the presence of a target nucleic acid in a sample
02/06/2003US20030027201 Method for mapping a nucleic acid
02/06/2003US20030027200 Biosensor for use in detection and measurement of preferential cellular activities
02/06/2003US20030027199 Measurement chip for biosensor
02/06/2003US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors
02/06/2003US20030027193 Non-isotopic rapid method and kit for measurement of levels of therapeutic compounds
1 ... 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 ... 3003